We continue to think that stock markets will make further headway against a backdrop of a recovering global economy and continued accommodative monetary policy, as investors increasingly focus on the rollout of effective vaccines rather than on rising case numbers and restrictions on economic activity.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to gain:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services